The University of Chicago Header Logo

Connection

Harriet De Wit to Central Nervous System Stimulants

Back to Details
This is a "connection" page, showing publications Harriet De Wit has written about Central Nervous System Stimulants.
Harriet De Wit
Connection Strength
17.102
Central Nervous System Stimulants
  1. The mesocorticolimbic system in stimulant use disorder. Mol Psychiatry. 2025 Nov; 30(11):5486-5499.
    View in: PubMed
    Score: 0.734
  2. Effects of methamphetamine on human effort task performance are unrelated to its subjective effects. Psychopharmacology (Berl). 2026 Jan; 243(1):199-209.
    View in: PubMed
    Score: 0.726
  3. Effects of methamphetamine on two measures of reward: Euphoria and neural activation to reward cues. Neuropsychopharmacology. 2025 Jul; 50(8):1298-1304.
    View in: PubMed
    Score: 0.715
  4. Neural correlates of inhibitory control are associated with stimulant-like effects of alcohol. Neuropsychopharmacology. 2021 07; 46(8):1442-1450.
    View in: PubMed
    Score: 0.543
  5. Subjective responses predict d-amphetamine choice in healthy volunteers. Pharmacol Biochem Behav. 2021 05; 204:173158.
    View in: PubMed
    Score: 0.537
  6. Stability of acute responses to drugs in humans across repeated testing: Findings with alcohol and amphetamine. Drug Alcohol Depend. 2020 07 01; 212:107989.
    View in: PubMed
    Score: 0.506
  7. Poor inhibitory control is associated with greater stimulation and less sedation following alcohol. Psychopharmacology (Berl). 2020 Mar; 237(3):825-832.
    View in: PubMed
    Score: 0.493
  8. Subjective responses to amphetamine in young adults with previous mood elevation experiences. Psychopharmacology (Berl). 2019 Nov; 236(11):3363-3370.
    View in: PubMed
    Score: 0.477
  9. Methamphetamine acutely alters frontostriatal resting state functional connectivity in healthy young adults. Addict Biol. 2020 05; 25(3):e12775.
    View in: PubMed
    Score: 0.474
  10. Effects of methamphetamine on neural responses to visual stimuli. Psychopharmacology (Berl). 2019 Jun; 236(6):1741-1748.
    View in: PubMed
    Score: 0.462
  11. Considering the context: social factors in responses to drugs in humans. Psychopharmacology (Berl). 2018 04; 235(4):935-945.
    View in: PubMed
    Score: 0.435
  12. MDMA does not alter responses to the Trier Social Stress Test in humans. Psychopharmacology (Berl). 2017 Jul; 234(14):2159-2166.
    View in: PubMed
    Score: 0.411
  13. Associations Between Behavioral and Neural Correlates of Inhibitory Control and Amphetamine Reward Sensitivity. Neuropsychopharmacology. 2017 Aug; 42(9):1905-1913.
    View in: PubMed
    Score: 0.408
  14. The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants? J Psychopharmacol. 2016 12; 30(12):1248-1258.
    View in: PubMed
    Score: 0.392
  15. Effects of d-amphetamine upon psychosocial stress responses. J Psychopharmacol. 2016 07; 30(7):608-15.
    View in: PubMed
    Score: 0.386
  16. Extinction of Conditioned Responses to Methamphetamine-Associated Stimuli in Healthy Humans. Psychopharmacology (Berl). 2016 07; 233(13):2489-502.
    View in: PubMed
    Score: 0.383
  17. Effects of acute methamphetamine on emotional memory formation in humans: encoding vs consolidation. PLoS One. 2015; 10(2):e0117062.
    View in: PubMed
    Score: 0.353
  18. Acquisition of responses to a methamphetamine-associated cue in healthy humans: self-report, behavioral, and psychophysiological measures. Neuropsychopharmacology. 2015 Jun; 40(7):1734-41.
    View in: PubMed
    Score: 0.351
  19. Amphetamine fails to alter cued recollection of emotional images: study of encoding, retrieval, and state-dependency. PLoS One. 2014; 9(2):e90423.
    View in: PubMed
    Score: 0.330
  20. Using conditioned place preference to identify relapse prevention medications. Neurosci Biobehav Rev. 2013 Nov; 37(9 Pt A):2081-6.
    View in: PubMed
    Score: 0.313
  21. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology (Berl). 2013 Jul; 228(1):109-18.
    View in: PubMed
    Score: 0.308
  22. Personality and the acute subjective effects of d-amphetamine in humans. J Psychopharmacol. 2013 Mar; 27(3):256-64.
    View in: PubMed
    Score: 0.306
  23. Does COMT genotype influence the effects of d-amphetamine on executive functioning? Genes Brain Behav. 2013 Feb; 12(1):13-20.
    View in: PubMed
    Score: 0.305
  24. Contextual conditioning enhances the psychostimulant and incentive properties of d-amphetamine in humans. Addict Biol. 2013 Nov; 18(6):985-92.
    View in: PubMed
    Score: 0.283
  25. Effects of amphetamine on reactivity to emotional stimuli. Psychopharmacology (Berl). 2012 Mar; 220(1):143-53.
    View in: PubMed
    Score: 0.279
  26. Effect of d-amphetamine on post-error slowing in healthy volunteers. Psychopharmacology (Berl). 2012 Mar; 220(1):109-15.
    View in: PubMed
    Score: 0.278
  27. More on ADORA. Psychopharmacology (Berl). 2010 Dec; 212(4):699-700.
    View in: PubMed
    Score: 0.259
  28. Stress-induced changes in mood and cortisol release predict mood effects of amphetamine. Drug Alcohol Depend. 2010 Jun 01; 109(1-3):175-80.
    View in: PubMed
    Score: 0.250
  29. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol. 2009 Dec; 17(6):374-83.
    View in: PubMed
    Score: 0.246
  30. Further evidence of association between amphetamine response and SLC6A2 gene variants. Psychopharmacology (Berl). 2009 Oct; 206(3):501-11.
    View in: PubMed
    Score: 0.243
  31. Does stress reactivity or response to amphetamine predict smoking progression in young adults? A preliminary study. Pharmacol Biochem Behav. 2007 Feb; 86(2):312-9.
    View in: PubMed
    Score: 0.196
  32. Subjective, behavioral, and physiological effects of acute caffeine in light, nondependent caffeine users. Psychopharmacology (Berl). 2006 May; 185(4):514-23.
    View in: PubMed
    Score: 0.190
  33. Menstrual cycle phase and responses to drugs of abuse in humans. Drug Alcohol Depend. 2006 Sep 01; 84(1):1-13.
    View in: PubMed
    Score: 0.188
  34. Methamphetamine Modulates Functional Connectivity Signatures of Sustained Attention and Arousal. Biol Psychiatry Cogn Neurosci Neuroimaging. 2026 Aug; 11(8):976-986.
    View in: PubMed
    Score: 0.186
  35. The effect of methamphetamine and 3,4-methylenedioxymethamphetamine on peripheral endocannabinoid concentrations: a study in healthy adults. Psychopharmacology (Berl). 2026 Feb; 243(2):413-426.
    View in: PubMed
    Score: 0.185
  36. The empathogen 3,4-methylenedioxymethamphetamine, but not methamphetamine, increases feelings of global trust. J Psychopharmacol. 2026 Sep; 40(9):1361-1367.
    View in: PubMed
    Score: 0.184
  37. Connectome-based encoding of subjective drug responses to acute oral methamphetamine. Neuropsychopharmacology. 2025 Nov; 50(12):1787-1794.
    View in: PubMed
    Score: 0.183
  38. Methamphetamine-induced adaptation of learning rate dynamics depend on baseline performance. Elife. 2025 Jul 21; 13.
    View in: PubMed
    Score: 0.182
  39. Social Homeostasis and Psychoactive Drugs: What Can We Learn From Opioid and Amphetamine Drug Challenge Studies in Humans? Biol Psychiatry. 2025 May 15; 97(10):982-988.
    View in: PubMed
    Score: 0.171
  40. Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers. J Psychopharmacol. 2024 11; 38(11):986-997.
    View in: PubMed
    Score: 0.170
  41. The 3,4-methylenedioxymethamphetamine enhances early visual processing for salient socio-emotional stimuli. Eur J Neurosci. 2024 06; 59(12):3224-3235.
    View in: PubMed
    Score: 0.167
  42. Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine. Neuropsychopharmacology. 2024 Jun; 49(7):1120-1128.
    View in: PubMed
    Score: 0.164
  43. The effects of acute haloperidol or risperidone on subjective responses to methamphetamine in healthy volunteers. Drug Alcohol Depend. 2002 Sep 01; 68(1):23-33.
    View in: PubMed
    Score: 0.149
  44. An fMRI study of the effect of amphetamine on brain activity. Neuropsychopharmacology. 2001 Dec; 25(6):925-35.
    View in: PubMed
    Score: 0.141
  45. Acute doses of d-amphetamine and bupropion increase cigarette smoking. Psychopharmacology (Berl). 2001 Sep; 157(3):243-53.
    View in: PubMed
    Score: 0.139
  46. Individual differences in responses to ethanol and d-amphetamine: a within-subject study. Alcohol Clin Exp Res. 2001 Apr; 25(4):540-8.
    View in: PubMed
    Score: 0.135
  47. Acute hydrocortisone administration does not affect subjective responses to d-amphetamine in humans. Psychopharmacology (Berl). 2001 Jan; 153(3):380-8.
    View in: PubMed
    Score: 0.133
  48. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol Biochem Behav. 2000 Jul; 66(3):509-15.
    View in: PubMed
    Score: 0.128
  49. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology. 2000 Jan; 71(1):51-9.
    View in: PubMed
    Score: 0.124
  50. Anticipation of monetary reward in amygdala, insula, caudate are predictors of pleasure sensitivity to d-Amphetamine administration. Drug Alcohol Depend. 2020 01 01; 206:107725.
    View in: PubMed
    Score: 0.122
  51. Acute effects of d-amphetamine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl). 1999 Jul; 145(1):67-75.
    View in: PubMed
    Score: 0.120
  52. Striatal activity correlates with stimulant-like effects of alcohol in healthy volunteers. Neuropsychopharmacology. 2018 12; 43(13):2532-2538.
    View in: PubMed
    Score: 0.112
  53. Neural activation to monetary reward is associated with amphetamine reward sensitivity. Neuropsychopharmacology. 2018 07; 43(8):1738-1744.
    View in: PubMed
    Score: 0.109
  54. Neural responses to cues paired with methamphetamine in healthy volunteers. Neuropsychopharmacology. 2018 07; 43(8):1732-1737.
    View in: PubMed
    Score: 0.108
  55. Effects of d-amphetamine in grouped versus isolated humans. Pharmacol Biochem Behav. 1997 May-Jun; 57(1-2):333-40.
    View in: PubMed
    Score: 0.103
  56. Interaction of expectancy and the pharmacological effects of d-amphetamine: subjective effects and self-administration. Psychopharmacology (Berl). 1996 Jun; 125(4):371-8.
    View in: PubMed
    Score: 0.097
  57. Individual differences in timing of peak positive subjective responses to d-amphetamine: Relationship to pharmacokinetics and physiology. J Psychopharmacol. 2016 Apr; 30(4):330-43.
    View in: PubMed
    Score: 0.095
  58. Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men. J Clin Psychopharmacol. 1996 Feb; 16(1):72-6.
    View in: PubMed
    Score: 0.094
  59. Subjective responses to d-amphetamine alone and after pimozide pretreatment in normal, healthy volunteers. Biol Psychiatry. 1996 Jan 01; 39(1):26-32.
    View in: PubMed
    Score: 0.094
  60. Effects of acute doses of prosocial drugs methamphetamine and alcohol on plasma oxytocin levels. J Clin Psychopharmacol. 2015 Jun; 35(3):308-12.
    View in: PubMed
    Score: 0.090
  61. Amphetamine increases errors during episodic memory retrieval. J Clin Psychopharmacol. 2014 Feb; 34(1):85-92.
    View in: PubMed
    Score: 0.082
  62. Inattention, impulsive action, and subjective response to D-amphetamine. Drug Alcohol Depend. 2013 Nov 01; 133(1):127-33.
    View in: PubMed
    Score: 0.079
  63. Genetic factors modulating the response to stimulant drugs in humans. Curr Top Behav Neurosci. 2012; 12:537-77.
    View in: PubMed
    Score: 0.071
  64. Personality and gender differences in effects of d-amphetamine on risk taking. Exp Clin Psychopharmacol. 2007 Dec; 15(6):599-609.
    View in: PubMed
    Score: 0.054
  65. Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry. 2007 Jun 01; 61(11):1296-305.
    View in: PubMed
    Score: 0.050
  66. Personality and the subjective effects of acute amphetamine in healthy volunteers. Neuropsychopharmacology. 2006 May; 31(5):1064-74.
    View in: PubMed
    Score: 0.048
  67. Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology. 2006 May; 31(5):1056-63.
    View in: PubMed
    Score: 0.048
  68. Interindividual variation in anxiety response to amphetamine: possible role for adenosine A2A receptor gene variants. Am J Med Genet B Neuropsychiatr Genet. 2005 Nov 05; 139B(1):42-4.
    View in: PubMed
    Score: 0.046
  69. Subjective effects of slow-release bupropion versus caffeine as determined in a quasi-naturalistic setting. Pharmacology. 2004 Apr; 70(4):206-15.
    View in: PubMed
    Score: 0.042
  70. Effects of stress on responses to methamphetamine in humans. Psychopharmacology (Berl). 2003 Nov; 170(2):188-99.
    View in: PubMed
    Score: 0.039
  71. Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003 Sep; 28(9):1694-702.
    View in: PubMed
    Score: 0.039
  72. Lack of effects of acute estradiol on mood in postmenopausal women. Pharmacol Biochem Behav. 2002 Jan-Feb; 71(1-2):71-7.
    View in: PubMed
    Score: 0.036
  73. Emotional traits predict individual differences in amphetamine-induced positive mood in healthy volunteers. Psychopharmacology (Berl). 2016 Jan; 233(1):89-97.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.